Pegavision Inkomsten in het verleden
Verleden criteriumcontroles 4/6
Pegavision is de winst gegroeid met een gemiddeld jaarlijks percentage van 26.8%, terwijl de Medical Equipment industrie de winst jaarlijks groeide met 9.6%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 16.4% per jaar. Het rendement op eigen vermogen van Pegavision is 18.9%, en het heeft een nettomarge van 28.3%.
Belangrijke informatie
26.8%
Groei van de winst
24.3%
Groei van de winst per aandeel
| Medical Equipment Groei van de industrie | 11.5% |
| Inkomstengroei | 16.4% |
| Rendement op eigen vermogen | 18.9% |
| Nettomarge | 28.3% |
| Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Impressive Earnings May Not Tell The Whole Story For Pegavision (TWSE:6491)
Nov 06
Pegavision's (TWSE:6491) Earnings Aren't As Good As They Appear
May 07Recent updates
Impressive Earnings May Not Tell The Whole Story For Pegavision (TWSE:6491)
Nov 06Pegavision Corporation (TWSE:6491) Just Reported Earnings, And Analysts Cut Their Target Price
Nov 01There's No Escaping Pegavision Corporation's (TWSE:6491) Muted Earnings
Oct 29At NT$428, Is Pegavision Corporation (TWSE:6491) Worth Looking At Closely?
Sep 25Pegavision Corporation Just Missed Revenue By 6.6%: Here's What Analysts Think Will Happen Next
Aug 01Pegavision Corporation (TWSE:6491) Screens Well But There Might Be A Catch
Jul 03Pegavision's (TWSE:6491) Dividend Will Be NT$10.00
May 27Pegavision (TWSE:6491) Has A Pretty Healthy Balance Sheet
May 23Pegavision's (TWSE:6491) Earnings Aren't As Good As They Appear
May 07Earnings Beat: Pegavision Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
May 05Pegavision Corporation (TWSE:6491) Shares Could Be 47% Below Their Intrinsic Value Estimate
May 02Is Pegavision Corporation (TWSE:6491) Potentially Undervalued?
Mar 14Is Pegavision (TPE:6491) Using Too Much Debt?
Apr 19What Does Pegavision Corporation's (TPE:6491) Share Price Indicate?
Apr 08Growth Investors: Industry Analysts Just Upgraded Their Pegavision Corporation (TPE:6491) Revenue Forecasts By 17%
Mar 28Here’s What’s Happening With Returns At Pegavision (TPE:6491)
Mar 18Is It Worth Buying Pegavision Corporation (TPE:6491) For Its 1.9% Dividend Yield?
Mar 03Do Pegavision's (TPE:6491) Earnings Warrant Your Attention?
Feb 16
Did You Miss Pegavision's (TPE:6491) Impressive 264% Share Price Gain?
Feb 03Pegavision Corporation's (TPE:6491) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Jan 19What Is The Ownership Structure Like For Pegavision Corporation (TPE:6491)?
Jan 06Is There An Opportunity With Pegavision Corporation's (TPE:6491) 41% Undervaluation?
Dec 21Why Pegavision Corporation (TPE:6491) Could Be Worth Watching
Dec 09Here’s What’s Happening With Returns At Pegavision (TPE:6491)
Nov 24Opbrengsten en kosten
Hoe Pegavision geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 7,060 | 1,996 | 1,088 | 634 |
| 30 Jun 24 | 7,078 | 1,936 | 1,122 | 640 |
| 31 Mar 24 | 7,055 | 1,827 | 1,104 | 635 |
| 31 Dec 23 | 6,790 | 1,656 | 1,095 | 592 |
| 30 Sep 23 | 6,528 | 1,501 | 1,027 | 579 |
| 30 Jun 23 | 6,493 | 1,544 | 962 | 548 |
| 31 Mar 23 | 6,292 | 1,521 | 914 | 558 |
| 31 Dec 22 | 6,321 | 1,542 | 920 | 576 |
| 30 Sep 22 | 6,099 | 1,491 | 933 | 576 |
| 30 Jun 22 | 5,971 | 1,431 | 941 | 580 |
| 31 Mar 22 | 5,938 | 1,384 | 977 | 571 |
| 31 Dec 21 | 5,595 | 1,249 | 958 | 547 |
| 30 Sep 21 | 5,454 | 1,162 | 965 | 523 |
| 30 Jun 21 | 4,949 | 1,004 | 921 | 477 |
| 31 Mar 21 | 4,403 | 849 | 841 | 420 |
| 31 Dec 20 | 3,978 | 715 | 774 | 374 |
| 30 Sep 20 | 3,564 | 612 | 683 | 336 |
| 30 Jun 20 | 3,412 | 516 | 644 | 313 |
| 31 Mar 20 | 3,317 | 463 | 622 | 287 |
| 31 Dec 19 | 3,355 | 475 | 621 | 280 |
| 30 Sep 19 | 3,206 | 449 | 587 | 261 |
| 30 Jun 19 | 3,217 | 522 | 577 | 245 |
| 31 Mar 19 | 3,184 | 540 | 579 | 249 |
| 31 Dec 18 | 3,133 | 541 | 576 | 238 |
| 30 Sep 18 | 2,877 | 475 | 551 | 234 |
| 30 Jun 18 | 2,604 | 380 | 526 | 238 |
| 31 Mar 18 | 2,393 | 341 | 494 | 234 |
| 31 Dec 17 | 2,182 | 303 | 462 | 230 |
| 30 Sep 17 | 2,030 | 275 | 437 | 226 |
| 30 Jun 17 | 1,878 | 247 | 412 | 222 |
| 31 Mar 17 | 1,769 | 217 | 395 | 223 |
| 31 Dec 16 | 1,659 | 187 | 379 | 225 |
| 30 Sep 16 | 1,573 | 165 | 368 | 223 |
| 30 Jun 16 | 1,487 | 143 | 358 | 222 |
| 31 Mar 16 | 1,398 | 135 | 345 | 212 |
| 31 Dec 15 | 1,308 | 127 | 332 | 201 |
| 30 Sep 15 | 1,231 | 119 | 311 | 189 |
| 30 Jun 15 | 1,155 | 110 | 291 | 177 |
| 31 Mar 15 | 1,038 | 90 | 268 | 158 |
| 31 Dec 14 | 921 | 69 | 244 | 139 |
| 30 Sep 14 | 797 | 51 | 225 | 123 |
| 30 Jun 14 | 674 | 32 | 205 | 108 |
| 31 Mar 14 | 632 | 38 | 189 | 109 |
| 31 Dec 13 | 589 | 45 | 172 | 111 |
Kwaliteitswinsten: 6491 heeft een hoog niveau van non-cash earnings.
Groeiende winstmarge: De huidige netto winstmarges (28.3%) 6491 } zijn hoger dan vorig jaar (23%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: De winst van 6491 is de afgelopen 5 jaar aanzienlijk gegroeid met 26.8% per jaar.
Versnelling van de groei: De winstgroei van 6491 over het afgelopen jaar ( 33% ) overtreft het 5-jarig gemiddelde ( 26.8% per jaar).
Winst versus industrie: De winstgroei 6491 over het afgelopen jaar ( 33% ) overtrof de Medical Equipment -sector 1.7%.
Rendement op eigen vermogen
Hoge ROE: Het Rendement op eigen vermogen ( 18.9% ) van 6491 wordt als laag beschouwd.